Status:
UNKNOWN
Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy
Lead Sponsor:
Diaa Eldin Taha Ramadan Mohamed
Conditions:
Nephrolithiasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Efficacy of ciprofloxacin therapy in avoidance of sepsis in patient undergoing percutanous nephrolithotomy. A randomized controlled trial.
Detailed Description
To figure out the value of oral ciprofloxacin medication in ameliorate the outcome of renal nephrolithiasis extraction via the endoscope as regard the sepsis.
Eligibility Criteria
Inclusion
- 1\. Patient 18 years or older
- Stones ≥ 2 cm and/or mild to moderate hydronephrosis
- Sterile mid urine stream
Exclusion
- Patients with a stent, nephrostomy tube or indwelling catheter
- Renal failure
- Fever before surgery
- Previous manipulation/procedure
- Concomitant bladder stone or tumour
- Patients with active UTI
- Contralateral renal/ureteric stone
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04374188
Start Date
September 1 2019
End Date
March 1 2022
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelsheikh faculty of medicine
Kafr ash Shaykh, Kafrelsheikh, Egypt